Several studies of EMMPRIN in tumor tissues showed that increased expression is associated with clinically aggressive behavior and poor prognosis in a variety of human cancers [12-20], and Liang et al. [21] reported that EMMPRIN expression was significantly associated with prognosis in advanced RCC. This evidence concerns the gene BSG and renal cell carcinoma.